×
Contact us
Send us your question or query through this form and we will respond as soon as possible.

The excellence in
One Health

Nano1Health SL is a company based on the rapid and precise identification of microorganisms and pathogens from a One Health perspective
About us

What?

We develop innovative strategies for rapidly identifying microorganisms, pathogens, and drug resistance biomarkers through metagenomic analysis. We offer solutions based on nanopore genomic sequencing and expert bioinformatic analysis.

MICROBIOME
Microbiome analyses from human, animal, and environmental samples.
– complete 16S rRNA gene for bacteria, with resolution at species level,
– 18S-ITS-28S for fungi
– metagenomics approach.

 

PATHOGEN IDENTIFICATION
Rapid identification of pathogens and drug resistance genes by agnostic metagenomics sequencing (a single process to identify viruses, bacteria, fungi, and parasites).

 

WHOLE GENOME SEQUENCING (microorganisms)
In-depth characterization of pathogens and drug resistance genes by nanopore whole-genome sequencing from microbiological cultures (complete genomes)

 

NANOPORE SEQUENCING
Long reads nanopore sequencing (GridION, Oxford Nanopore Technologies), bioinformatics analyses and data storage.

 

As a CRO, we can counsel our customers with their projects, considering the data generation process (sequencing) and developing or adapting specific bioinformatic algorithms and pipelines tailored to their needs.

Contact us
Nano_Health_grafica

How?

Our multidisciplinary team stands out for its expertise in genomics,

bioinformatics, and veterinary medicine. We offer a close and personalized contact for each client.

icon-1

Knowledge

The team’s previous
expertise and
complementarity.
icon-2

Innovation

State-of-the-art tools, prepared
to offer innovative, precise,
and affordable solutions.
icon-3

Unique

With a One Health vision

Who?

Nano1Health is a B2B company, joining the expertise of highly valued veterinarians, geneticists, and bioinformaticians.

 

We are a multidisciplinary team, which stands out for its long history and experience in the field of genetics.

01 / 09
unnamed

OLGA FRANCINO

PhD Biology
Founding partner of Nano1Health and Vetgenomics, team leader with extensive experience in the implementation and valorization of new genomic methodologies. She is also responsible for Project Management and Innovation of the Molecular Genetics Veterinary Service (SVGM, UAB).
N1H-LLUIS FERRER

LLUIS FERRER

DVM, PhD, Dipl ECVD
Founding partner of Nano1Health. His research over the last 30 years has focused on understanding the molecular mechanisms of some canine skin diseases, with the ultimate goal of using the dog as a primary non-rodent model for human disease.
N1H-MARC-NOGUERA_bn

MARC NOGUERA

PhD Chemistry
Founding partner of Nano1Health. Marc works between computing and science. He has strong skills in molecular modeling, genomics, high-performance computing, drug discovery, and DNA sequencing analysis. His specialties are: Chemoinformatics, Bioinformatics, Genomics, High Performance Sequencing, High Performance Computing, Cloud Computing and Data Analysis.
N1H-XAVI-ROURA_bn

XAVIER ROURA

DVM, PhD, Dipl ECVIM-CA
Founding partner of Nano1Health. Xavi is a veterinarian specializing in small animal internal medicine at the Hospital Clínic Veterinari of the Universitat Autònoma de Barcelona (Spain) and current president of the International Society of Renal Interest and an active member of the Canine Leishmaniasis Study Group.
N1H-MONTSE-SALA_bn

MONTSE SALA

PhD
Founding partner of Nano1Health. Her work is focused on implementing and maintaining the Quality Management System, promoting Continuous Improvement. She supervises the activities carried out by the team in terms of quality and their responsibilities to verify compliance with legal, customer and internal requirements.
N1H-joan-marti_bn

JOAN MARTÍ-CARRERAS

PhD
Joan has a Ph.D. in Biomedical Sciences from KU Leuven (Belgium) and is one of the talent recruits with the Neotec grant. His specialties are virology (mainly human pathogens), bioinformatics, and epidemic/pandemic control. Joan has extensive experience in Illumina and Oxford Nanopore sequencing to obtain viral genomes and analyze their variation in a functional, phylogenetic and epidemiological context.
N1H-MarcelGomezPonce_bn

MARCEL GÓMEZ PONCE

Veterinarian graduated from the UAB. His great passion for wildlife and pathology led him to work as a vet intern in the Pathology Department of the UAB and in a Seal Rescue Center in The Netherlands. Nowadays, he seeks to expand his knowledge and research skills in genomics applied to animal health and infectious diseases
N1H-MarinaCarrasco_bn

MARINA CARRASCO

– Industrial Doctorate PhD student. Graduated in Biotechnology in 2021 by Universitat de Barcelona. Internship in the Virus Contaminants d’Aigua i Aliments laboratory. MSc in Zoonosis and One Health in 2022 by Univeristat Autònoma de Barcelona. Intership in Nano1Health S.L.
N1H-DanielPerez_bn

DANIEL PÉREZ

Daniel is a biochemist who specialises in clinical analysis. He has experience in DNA sequencing with Oxford Nanopore Technologies, microbiome and whole genome sequencing of bacterial genomes analysis. Also, he has participated in the planning and administration of several veterinarian research projects, establishing and validating genomic analysis methods.

Our clients

We work in different sectors
with extensive research experience.
image-triangle-1
  • Pharmaceutical, veterinary, biomedical, and agri-food research professionals
  • Research groups or companies with R+D+i projects
  • Professionals from the agri-food sector
  • Public and private research professionals